LifeStance director proposes $2.28M share sale
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
LifeStance Health Group, Inc. (LFST) director Kenneth A. Burdick reported a proposed sale of 159,624 common shares, with an approximate sale date of November 12, 2026, and aggregate market value of $2,284,844.97. The notice lists 380,190,724 common shares outstanding.
It also lists Burdick's sales of 66,589 common shares for gross proceeds of $959,715.86 on November 9, 2026, and 75,000 shares for $1,095,082.50 on November 10, 2026. The 159,624 shares listed for proposed sale were acquired from the issuer through a stock option exercise on November 12, 2026, with cash payment.
Key Figures
Key Terms
Stock Option Exercise financial
Aggregate Market Value financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
AI-generated analysis. How Rhea-AI works. Not financial advice.